HUTCHMED (China) Limited
IPOPublic · Hong Kong, Hong Kong · Founded 2000 · $100.0M raised
- Headquarters
- Hong Kong
- Employees
- 1001–5000
- Founded
- 2000
- Business Model
- B2B
- Website
- hutch-med.com
- Total Funding
- $100.0M
- Last Round
- $100.0M Private EquityJan 2013
- Rounds
- 1
- Type
- Public
About
Innovative commercial-stage biopharmaceutical company discovering and developing targeted therapies for cancer and immunological diseases.
Summary
HUTCHMED (China) Limited is a Biotech company based in Hong Kong, Hong Kong, founded in 2000. It has raised $100.0M in total across 1 round, most recently a $100.0M Private Equity round in Jan 2013. Investors include Baring Private Equity, Canada Pension Plan Investment Board and The Carlyle Group.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Oct 2021
Sign up to see all 4 rounds
IPO through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Global biosimulation software and services company accelerating drug development for 2,000+ bioph...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hutchmed-china-limited"><img src="https://indexed.vc/api/badge/company/hutchmed-china-limited" alt="HUTCHMED (China) Limited on Indexed.vc" width="260" height="76" /></a>